TY - JOUR
T1 - Retraction
T2 - Withdrawal: Antioncogenic and oncogenic properties of Nrf2 in arsenic-induced carcinogenesis (Journal of Biological Chemistry (2015) 290 (27090-27100) DOI: 10.1074/jbc.M115.675371)
AU - Son, Young Ok
AU - Pratheeshkumar, Poyil
AU - Roy, Ram Vinod
AU - Hitron, John Andrew
AU - Wang, Lei
AU - Divya, Sasidharan Padmaja
AU - Xu, Mei
AU - Luo, Jia
AU - Chen, Gang
AU - Zhang, Zhuo
AU - Shi, Xianglin
N1 - Publisher Copyright:
© 2018 by The American Society for Biochemistry and Molecular Biology, Inc.
PY - 2018/10/5
Y1 - 2018/10/5
N2 - This article has been withdrawn by the authors. The corresponding author identified some issues and brought them to the attention of the Journal. The following issues were discovered in the article. The GAPDH immunoblot in Fig. 5A was reused in Figs. 1H, 2F, 2I, 3B, 3G, and 5B. The ESR spectrum from BEAS-2B cells in Fig. 2Awas previously published in Son et al. ((2014) J. Biol. Chem. 289, 28660-28675) without attribution. The BEAS-2B image in Fig. 2C was reused in Fig. 6A as control siRNA. The GAPDH immunoblot from Fig. 3A was previously published in Fig. 4A of Son et al. ((2014) J. Biol. Chem. 289, 28660- 28675), representing different experimental conditions. The GAPDH immunoblot from Fig. 3D was reused in Fig. 3I. A portion of the same immunoblot was reused in Fig. 4Aas actin. Lanes 9-12 of theβ-actin gel in Fig. 4B was reused in lanes 9-10 of the Bcl-xL ARE F1 gel in Fig. 4E. Fig. 5B contained several undeclared splices. In Fig. 5C, the control images for BEAS-2B and AsT cells were reused.
AB - This article has been withdrawn by the authors. The corresponding author identified some issues and brought them to the attention of the Journal. The following issues were discovered in the article. The GAPDH immunoblot in Fig. 5A was reused in Figs. 1H, 2F, 2I, 3B, 3G, and 5B. The ESR spectrum from BEAS-2B cells in Fig. 2Awas previously published in Son et al. ((2014) J. Biol. Chem. 289, 28660-28675) without attribution. The BEAS-2B image in Fig. 2C was reused in Fig. 6A as control siRNA. The GAPDH immunoblot from Fig. 3A was previously published in Fig. 4A of Son et al. ((2014) J. Biol. Chem. 289, 28660- 28675), representing different experimental conditions. The GAPDH immunoblot from Fig. 3D was reused in Fig. 3I. A portion of the same immunoblot was reused in Fig. 4Aas actin. Lanes 9-12 of theβ-actin gel in Fig. 4B was reused in lanes 9-10 of the Bcl-xL ARE F1 gel in Fig. 4E. Fig. 5B contained several undeclared splices. In Fig. 5C, the control images for BEAS-2B and AsT cells were reused.
UR - http://www.scopus.com/inward/record.url?scp=85054429138&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85054429138&partnerID=8YFLogxK
U2 - 10.1074/jbc.W118.005758
DO - 10.1074/jbc.W118.005758
M3 - Comment/debate
C2 - 30291177
AN - SCOPUS:85054429138
SN - 0021-9258
VL - 293
SP - 15456
JO - Journal of Biological Chemistry
JF - Journal of Biological Chemistry
IS - 40
ER -